Advertisement
UK markets closed
  • FTSE 100

    7,820.36
    -145.17 (-1.82%)
     
  • FTSE 250

    19,344.54
    -354.35 (-1.80%)
     
  • AIM

    740.18
    -10.10 (-1.35%)
     
  • GBP/EUR

    1.1701
    -0.0010 (-0.08%)
     
  • GBP/USD

    1.2437
    -0.0010 (-0.08%)
     
  • Bitcoin GBP

    49,724.28
    -2,243.93 (-4.32%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,066.32
    +4.50 (+0.09%)
     
  • DOW

    37,917.28
    +182.17 (+0.48%)
     
  • CRUDE OIL

    85.55
    +0.14 (+0.16%)
     
  • GOLD FUTURES

    2,400.80
    +17.80 (+0.75%)
     
  • NIKKEI 225

    38,471.20
    -761.60 (-1.94%)
     
  • HANG SENG

    16,248.97
    -351.49 (-2.12%)
     
  • DAX

    17,766.23
    -260.35 (-1.44%)
     
  • CAC 40

    7,932.61
    -112.50 (-1.40%)
     

Danaher (DHR) Outpaces Stock Market Gains: What You Should Know

Danaher (DHR) closed the most recent trading day at $232.69, moving +1.34% from the previous trading session. This change outpaced the S&P 500's 0.99% gain on the day.

Heading into today, shares of the industrial and medical device maker had lost 6.5% over the past month, lagging the Conglomerates sector's loss of 1.44% and the S&P 500's gain of 0.42% in that time.

Investors will be hoping for strength from Danaher as it approaches its next earnings release. On that day, Danaher is projected to report earnings of $2.01 per share, which would represent a year-over-year decline of 27.17%. Our most recent consensus estimate is calling for quarterly revenue of $7.1 billion, down 8.36% from the year-ago period.

DHR's full-year Zacks Consensus Estimates are calling for earnings of $9.44 per share and revenue of $29.44 billion. These results would represent year-over-year changes of -13.79% and -6.45%, respectively.

ADVERTISEMENT

Any recent changes to analyst estimates for Danaher should also be noted by investors. Recent revisions tend to reflect the latest near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.

Research indicates that these estimate revisions are directly correlated with near-term share price momentum. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.

The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 1.11% lower. Danaher is currently sporting a Zacks Rank of #4 (Sell).

In terms of valuation, Danaher is currently trading at a Forward P/E ratio of 24.33. Its industry sports an average Forward P/E of 14.83, so we one might conclude that Danaher is trading at a premium comparatively.

Meanwhile, DHR's PEG ratio is currently 2.32. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. Diversified Operations stocks are, on average, holding a PEG ratio of 1.67 based on yesterday's closing prices.

The Diversified Operations industry is part of the Conglomerates sector. This group has a Zacks Industry Rank of 178, putting it in the bottom 30% of all 250+ industries.

The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

To follow DHR in the coming trading sessions, be sure to utilize Zacks.com.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Danaher Corporation (DHR) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research